Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000359154

Medchemexpress LLC Palbociclib hydrochloride | 571189-11-2 | 100.0% | C24H30ClN7O2 | 2 G
SDP

Catalog No. 5000359154
Encompass_Preferred

Palbociclib hydrochloride is an orally active, selective inhibitor of CDK4 and CDK6, with IC50 values of 11 nM and 16 nM respectively. It demonstrates potent anti-proliferative activity and is known to induce cell cycle arrest in various cancer cells. This compound is suitable for research in HR-positive and HER2-negative breast cancer, as well as hepatocellular carcinoma.

  • Orally active selective CDK4 and CDK6 inhibitor
  • Potent anti-proliferative activity
  • Induces cell cycle arrest in cancer cells
  • Used in research for HR-positive and HER2-negative breast cancer and hepatocellular carcinoma

Catalog No. 50-003-59154 Supplier Medchemexpress LLC Supplier No. HY50767C2G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Palbociclib hydrochloride is an orally active, selective inhibitor of CDK4 and CDK6, with IC50 values of 11 nM and 16 nM respectively. It demonstrates potent anti-proliferative activity and is known to induce cell cycle arrest in various cancer cells. This compound is suitable for research in HR-positive and HER2-negative breast cancer, as well as hepatocellular carcinoma.

  • Orally active selective CDK4 and CDK6 inhibitor
  • Potent anti-proliferative activity
  • Induces cell cycle arrest in cancer cells
  • Used in research for HR-positive and HER2-negative breast cancer and hepatocellular carcinoma

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.